"Botanical Solution Raises $7.6M in Series A Funding for Vaccine Development and Expansion"
Botanical Solution Raises Additional $7.6M; Series A Extended to Over $23M
Botanical Solution Raises $7.6M in Series A Funding
Botanical Solution (Linkedin), a Chile-based business consulting and services company, has secured an additional $7.6 million in funding for their vaccine development initiatives. With a focus on scaling production and expanding R&D; capabilities, Botanical Solution aims to partner with vaccine developers, pharmaceutical companies, and healthcare providers in the biotechnology and healthcare sectors.
Funding Amount: $7.6 million (Total Series A funding: $23 million)
Industry: Business Consulting and Services
Employee Count: 2-10
CEO: Gastón Salinas (CEO Linkedin)
What Botanical Solution needs to buy: Manufacturers specializing in vaccine production, research institutions with expertise in adjuvants and botanical materials, and market expansion services are ideal partners for Botanical Solution. These collaborations will support their goal of scaling production, advancing R&D;, and expanding into new markets, ultimately contributing to the development of innovative vaccine solutions.